# FDA recall D-1422-2012

> **Pack Pharmaceuticals** · Class III · drug recall initiated 2012-03-09.

## Product

Ciprofloxacin Tablets, USP, 500 mg, Rx Only, 100 Tablets per Bottle, Manufactured in India by: Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai - 400 030, Distributed by: PACK Pharmaceuticals, LLC, Buffalo Grove, IL 60089, NDC 16571-412-10.

## Reason for recall

Labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is being initiated due to two bottles missing container labels.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1422-2012
- **Recalling firm:** Pack Pharmaceuticals
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-03-09
- **Report date:** 2012-07-25
- **Termination date:** 2012-07-19

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Buffalo Grove, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1422-2012

## Citation

> AI Analytics. FDA recall D-1422-2012. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-1422-2012. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*